Lantheus Holdings, Inc. 13D and 13G filings for PROGENICS PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-23 10:26 am Sale |
2020-06-19 | 13D | PROGENICS PHARMACEUTICALS INC PGNX |
Lantheus Holdings Inc. LNTH |
1,000 100.000% |
-8,010,733 (-99.99%) |
Filing |